MX9706133A - Medicament intended to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness. - Google Patents

Medicament intended to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness.

Info

Publication number
MX9706133A
MX9706133A MX9706133A MX9706133A MX9706133A MX 9706133 A MX9706133 A MX 9706133A MX 9706133 A MX9706133 A MX 9706133A MX 9706133 A MX9706133 A MX 9706133A MX 9706133 A MX9706133 A MX 9706133A
Authority
MX
Mexico
Prior art keywords
emesa
troubles
treatment
obsessive compulsive
sexual dysfunctions
Prior art date
Application number
MX9706133A
Other languages
Spanish (es)
Other versions
MXPA97006133A (en
Inventor
Jordi Frigola Constansa
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of MX9706133A publication Critical patent/MX9706133A/en
Publication of MXPA97006133A publication Critical patent/MXPA97006133A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention relates to the use of derivatives of 1-{4-[4-aryl(or heteroaryl)-1-piperazinyl]-butyl}-1H-azole, as well as physiologically acceptable salts thereof, for the fabrication of medicaments intented to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness.
MXPA/A/1997/006133A 1995-12-12 1997-08-11 Use of derivatives of 1-. { 4- [4-aril (o heteroaril) -1-piperazinil] -butil} -1h-azol for the preparation of a medicinal product intended for the treatment of obsessive-compulsive disorders, of the apnea delsueño, of the sexual dysfunctions, of the eme MXPA97006133A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9514690A FR2742052B1 (en) 1995-12-12 1995-12-12 USE OF DERIVATIVES 1- (4- (4-ARYL (OR HETEROARYL) -1-PIPER AZINYL) -BUTY) -1H-AZOLE FOR THE TREATMENT OF DEPRESSION, OBSESSIVE COMPULSIVE DISORDERS, SLEEP APNEA, SEXUAL DYSFUNCTIONS , Emese and motion sickness
FR95/14690 1995-12-12
FR9514690 1995-12-12
PCT/EP1996/005736 WO1997021439A1 (en) 1995-12-12 1996-12-11 Medicament intended to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness

Publications (2)

Publication Number Publication Date
MX9706133A true MX9706133A (en) 1997-11-29
MXPA97006133A MXPA97006133A (en) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
ES2134709A1 (en) 1999-10-01
CZ255197A3 (en) 1998-01-14
ES2134709B1 (en) 2000-05-16
ZA9610457B (en) 1997-06-24
AU1376497A (en) 1997-07-03
HUP9800198A2 (en) 1999-09-28
JPH11501051A (en) 1999-01-26
CN1177297A (en) 1998-03-25
NO973589D0 (en) 1997-08-04
EP0808166A1 (en) 1997-11-26
AU716665B2 (en) 2000-03-02
FR2742052B1 (en) 1998-04-10
PL321779A1 (en) 1997-12-22
WO1997021439A1 (en) 1997-06-19
IL121461A0 (en) 1998-02-08
NO973589L (en) 1997-10-08
TR199700794T1 (en) 1997-11-21
FR2742052A1 (en) 1997-06-13
AR004378A1 (en) 1998-11-04
CA2211161A1 (en) 1997-06-19

Similar Documents

Publication Publication Date Title
MXPA03007712A (en) Pharmaceutical salts.
ES2134709A1 (en) Medicament intended to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness
BG106095A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
CA2386690A1 (en) Pharmaceutical tramadol salts
NO954996L (en) Use of nona and decapeptides for the manufacture of a medicament for the treatment of AIDS
MY127980A (en) A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
IL113566A0 (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
PL309604A1 (en) Pharmaceutical composition for treating nicotin dependence
EE200300514A (en) Phthalazinones, their use in the manufacture of medicaments for the treatment of respiratory symptoms and medicinal products containing them
ATE243196T1 (en) PIPERIDINE AND PYRROLIDINE
WO2002088100A3 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
RU2218917C2 (en) Application of specific antagonist of 5ht2a-receptors for preparing drugs useful for treatment of sleep apnea syndrome
MX9805141A (en) USE OF INHIBITORS OF THE CELLULAR Na+/H+ EXCHANGER (NHE) FOR THE PREPARATION OF A DRUG FOR RESPIRATORY STIMULATION.
GR1004358B (en) Anhydrous crystalline valaciclivier hydrochloride
NO20015228D0 (en) Use of saredutant and its pharmaceutically acceptable salts for the manufacture of drugs used to treat or prevent mental disorders, adaptation disorders, or mixed anxiety-depression disorders
DE69918961D1 (en) IMPROVED INHALATION PRODUCTS
WO2002053149A3 (en) Medicament containing a polyamine as an active substance
MXPA02011533A (en) NOVEL FORMULATIONS OF agr; 2, 4 DISULFOPHENYL N TERT BUTYLNITRONE.
BR0009080A (en) Sleep apnea treatment method
BG105204A (en) Salts of paroxetine
IL164317A0 (en) Statin therapy for enhancing cognitive maintenance
CA2436537A1 (en) Pharmaceutical compositions comprising tiotropium salts and antihistamines
PL371518A1 (en) Method for producing crystals from active ingredients in medicaments, crystals obtained therefrom and the use thereof in pharmaceutical formulations
HK1011527A1 (en) Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases